[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343439-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343439-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-use-of-patient-derived-organoids-in-the-study-of-molecular-metabolic-adaptation-in-breast-cancer","The Use of Patient-Derived Organoids in the Study of Molecular Metabolic Adaptation in Breast Cancer","","Around 13% of women will develop breast cancer during their lifetime, and cancer metabolism research has revealed metabolic reprogramming events such as altered glucose and amino-acid uptake, increased glycolysis reliance, and tumor microenvironment (TME) interactions. Traditional 2D cultures poorly reproduce tumor architecture and dynamic metabolic crosstalk. This review uses patient-derived tumor organoid (PDTO) models to examine unique breast-cancer metabolic adaptations, assess advanced 3D tools like OMI and MALDI-MSI, and discuss progress toward metabolic therapeutic targets.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-use-of-patient-derived-organoids-in-the-study-of-molecular-metabolic-adaptation-in-breast-cancer/343439/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-use-of-patient-derived-organoids-in-the-study-of-molecular-metabolic-adaptation-in-breast-cancer/343439.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are patient-derived tumor organoids useful for studying breast cancer metabolism?","Question",{"text":63,"@type":64},"They are self-organized 3D cultures that better mimic the structural and functional properties of tumors in vivo than traditional 2D cultures, enabling more realistic study of metabolic adaptations.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What metabolic changes are highlighted as key features in cancer metabolism research?",{"text":68,"@type":64},"Metabolic alterations can include deregulated glucose and amino-acid uptake, increased glycolysis and TCA-related biosynthetic support, nitrogen demand changes, metabolite-driven gene regulation, nutrient-acquisition strategies, and interactions with the microenvironment.",{"name":70,"@type":61,"acceptedAnswer":71},"Which advanced tools for studying metabolism in 3D culture models are discussed?",{"text":72,"@type":64},"The review discusses optical metabolic imaging (OMI) and matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI), along with advances in conventional techniques for 3D cultures.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343439,1790921651,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Review  \nThe Use of Patient-Derived Organoids in the Study of Molecular Metabolic Adaptation in Breast Cancer  \nNatalija Glibetic 1,2,3, Scott Bowman 1,4, Tia Skaggs 1,5 and Michael Weichhaus 1, *  \nCitation: Glibetic, N.; Bowman, S.; Skaggs, T.; Weichhaus, M. The Use of Patient-Derived Organoids in the Study of Molecular Metabolic Adaptation in Breast Cancer. Int. J.  \nMol. Sci. 2024, 25, 10503. [https://](https://)[ ](https://)[doi.org/10.3390/ijms251910503](doi.org/10.3390/ijms251910503)  \nAcademic Editors: Geeta Upadhyay and Mary Lou Cutler  \nReceived: 31 August 2024  \nRevised: 24 September 2024  \nAccepted: 25 September 2024  \nPublished: 29 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Laboratory of Molecular Cancer Research, School of Natural Sciences and Mathematics, Chaminade University of Honolulu, Honolulu, HI 96816, USA; [natalija.glibetic@chaminade.edu](natalija.glibetic@chaminade.edu) (N.G.); [scott.bowman@student.chaminade.edu](scott.bowman@student.chaminade.edu) (S.B.); [tia.skaggs@student.chaminade.edu](tia.skaggs@student.chaminade.edu) (T.S.)  \n2 The IDeA Networks of Biomedical Research Excellence (INBRE) Program, School of Natural Sciences and Mathematics, Chaminade University, Honolulu, HI 96816, USA  \n3 United Nations CIFAL Honolulu Center, Chaminade University, Honolulu, HI 96816, USA  \n4 Undergraduate Program in Biochemistry, School of Natural Sciences and Mathematics, Chaminade University, Honolulu, HI 96816, USA  \n5 Undergraduate Program in Biology, School of Natural Sciences and Mathematics, Chaminade University, Honolulu, HI 96816, USA  \n* [Correspondence: michael.weichhaus@chaminade.edu](Correspondence: michael.weichhaus@chaminade.edu)  \nAbstract: Around 13% of women will likely develop breast cancer during their lifetime. Advancesin cancer metabolism research have identified a range of metabolic reprogramming events, such as altered glucose and amino acid uptake, increased reliance on glycolysis, and interactions with the tumor microenvironment (TME), all of which present new opportunities for targeted therapies. However, studying these metabolic networks is challenging in traditional 2D cell cultures, which often fail to replicate the three-dimensional architecture and dynamic interactions of real tumors. To address this, organoid models have emerged as powerful tools. Tumor organoids are 3D cultures, often derived from patient tissue, that more accurately mimic the structural and functional properties of actual tumor tissues in vivo, offering a more realistic model for investigating cancer metabolism. This review explores the unique metabolic adaptations of breast cancer and discusses how organoid models can provide deeper insights into these processes. We evaluate the most advanced tools for studying cancer metabolism in three-dimensional culture models, including optical metabolic imaging (OMI), matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDIMSI), and recent advances in conventional techniques applied to 3D cultures. Finally, we explore the progress made in identifying and targeting potential therapeutic targets in breast cancer metabolism.  \nKeywords: breast cancer; organoid; metabolism; glycolysis; lipid metabolism; optical metabolic imaging; MALDI-MSI; tumor microenvironment  \n1. Introduction  \nIn 2022, 42,211 women in the U.S. died from breast cancer; it continues to be one of the most prevalent forms of diagnosed cancers in women, with a one in eight (13%) lifetime risk of developing the disease [1,2] . Metabolic alterations in tumors were one of the first discoveries in cancer biology and can be categorized into six hallmarks: (1) dere","cbCaiftPzhBYsi6d","https://ap.wps.com/l/cbCaiftPzhBYsi6d","pdf",2198831,29,"English","# Abstract\n# Keywords\n# 1. Introduction\n## Cancer metabolism hallmarks and therapeutic rationale\n## Limitations of 2D models and need for TME-relevant systems\n## Patient-derived tumor organoids (PDTO): definition and utility","[{\"question\":\"Why are patient-derived tumor organoids useful for studying breast cancer metabolism?\",\"answer\":\"They are self-organized 3D cultures that better mimic the structural and functional properties of tumors in vivo than traditional 2D cultures, enabling more realistic study of metabolic adaptations.\"},{\"question\":\"What metabolic changes are highlighted as key features in cancer metabolism research?\",\"answer\":\"Metabolic alterations can include deregulated glucose and amino-acid uptake, increased glycolysis and TCA-related biosynthetic support, nitrogen demand changes, metabolite-driven gene regulation, nutrient-acquisition strategies, and interactions with the microenvironment.\"},{\"question\":\"Which advanced tools for studying metabolism in 3D culture models are discussed?\",\"answer\":\"The review discusses optical metabolic imaging (OMI) and matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI), along with advances in conventional techniques for 3D cultures.\"}]","The Use of Patient-Derived Organoids in the Study of Molecular Metabolic Adaptation in Breast Cancer | PDF",1790051194,73,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1302259645ac32b989eb0d9c59c1acf7.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed3df5b0a03428f611bba195bf8cf41f.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c981cd23c2a509b88545fd27db1d7e0.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51aa3ed65ea5a3c655c8e4578db973f7.webp",980,1385]